The levels of caspase-cleaved cytokeratin 18 are elevated in serum from patients with lung cancer and helpful to predict the survival.
about
Towards the Biological Understanding of CTC: Capture Technologies, Definitions and Potential to Create Metastasis.Circulating cell death products predict clinical outcome of colorectal cancer patientsConsiderations for the use of plasma cytokeratin 18 as a biomarker in pancreatic cancer.Nonalcoholic fatty liver disease: Diagnostic biomarkers.Elevation of serum fortilin levels is specific for apoptosis and signifies cell death in vivo.Keratins in health and cancer: more than mere epithelial cell markersEvaluation of cell death mechanisms induced by the vascular disrupting agent OXi4503 during a phase I clinical trial.Prognostic impact of circulating tumor cell apoptosis and clusters in serial blood samples from patients with metastatic breast cancer in a prospective observational cohortChemotherapy increases caspase-cleaved cytokeratin 18 in the serum of breast cancer patientsBiomarker method validation in anticancer drug developmentClinical evaluation of M30 and M65 ELISA cell death assays as circulating biomarkers in a drug-sensitive tumor, testicular cancer.Circulating biomarkers of cell death after treatment with the BH-3 mimetic ABT-737 in a preclinical model of small-cell lung cancer.Circulating Levels of M30 and M65 Molecules in Transitional Cell Carcinoma of the Bladder and Their Relation to Tumor Progression.A Multiplexed Cytokeratin Analysis Using Targeted Mass Spectrometry Reveals Specific Profiles in Cancer-Related Pleural EffusionsEvaluation of circulating tumor cells and serological cell death biomarkers in small cell lung cancer patients undergoing chemotherapyBiomarkers of apoptosis.The significance of caspase-cleaved cytokeratin 18 in pleural effusionUtilization of cytokeratin-based biomarkers for pharmacodynamic studies.Apoptosis: why and how does it occur in biology?Intermediate filament: structure, function, and applications in cytology.Mechanistic biomarkers in acetaminophen-induced hepatotoxicity and acute liver failure: from preclinical models to patients.The M30 assay does not detect apoptosis in epithelial-derived cancer cells expressing low levels of cytokeratin 18.Zoledronic acid induces caspase-dependent apoptosis in renal cancer cell lines.Prognostic Value of Serum Caspase-Cleaved Cytokeratin-18 Levels before Liver Transplantation for One-Year Survival of Patients with Hepatocellular CarcinomaA high serum level of M65 is associated with tumour aggressiveness and an unfavourable prognosis for epithelial ovarian cancer.Clinical significance of serum M30 and M65 levels in metastatic pancreatic adenocarcinoma.Orally administered S-1 suppresses circulating endothelial cell counts in metastatic breast cancer patients.Circulating tumor cells, tumor-derived extracellular vesicles and plasma cytokeratins in castration-resistant prostate cancer patients.The oxidant/antioxidant status and cell death mode in oral squamous cell carcinoma.Cytokeratin 18-based cell death markers indicate severity of liver disease and prognosis of cirrhotic patients.New prognostic biomarkers of mortality in patients undergoing liver transplantation for hepatocellular carcinoma
P2860
Q30445250-B589B1F4-64AB-4074-8E1C-B8759E579005Q33420106-383DBD17-7FDA-41A3-8F25-48733A0C6C9CQ33658526-7ECCF797-2E5F-4AEF-A57D-7F7A293E22D2Q33706254-6B48BE56-0F6E-4FBD-A52C-96F8D0D707B8Q34795048-BFFC5223-F797-4C92-BEEF-E167A1E8A770Q35161934-1F9FE071-0817-4E05-80AA-0F36882701F6Q35998447-5E82B583-F22A-45A4-953E-53AC2C8917ACQ36070763-63B62C00-1158-4C4B-A8AC-68BDAACD593AQ36177752-3FF7A7CB-83CD-48A7-8093-6DD9AB6D291EQ36484621-95DF7097-6F05-4149-A42F-55396854BC3BQ36897795-7E5A74CF-13D6-4F1F-A8F6-52FB0D579124Q36980678-C9F39C6D-0722-4930-BC90-A5A1400C725DQ37111059-B98CA507-8EF1-49BE-8BF1-4CD349ED8EDDQ37112709-7A9F9004-686D-4F91-A70F-E6289878EC8FQ37278502-28E1D7C8-A124-4913-870E-65D88F426536Q37400048-72F3A688-345F-4FC4-A3AB-6EADF528A132Q37575189-510D0AC1-4F75-4487-9BC6-D7DBBF91590DQ37724878-BB65CE17-CAAF-459B-8729-C12B1878DA36Q37902996-18E20F07-3690-4689-B68D-DDB20FCC7D3AQ38193018-D0776167-F8AE-4760-BDE9-8390565BA32BQ38212434-4F3348C5-AA22-4A36-BDB3-6E75563F7ECDQ38890416-E568952B-49E5-49B6-9601-1593A670684FQ39902586-0B021943-4867-48D0-8877-3381D0717C9CQ41191656-38EEF67D-18AE-4BDB-B62F-A2B0B90571E2Q43421009-F16AA1C3-7A0B-4A40-807E-3ACA22BD786AQ50893230-6C794696-B5FD-4B7A-8FCD-2318424E3B06Q50933865-0B9507BF-847B-403B-ACB2-B099BE74ED22Q52714347-2EB19861-3B4B-48A1-9D84-6621A5CEC4C7Q53283602-5B959C1B-DB84-4A00-9A26-E21796612EA1Q54634837-7C856EB5-BFF3-47AB-8F9D-45CCB1518712Q57482211-1421AF0E-128B-4247-8DF9-E3693E02BB2D
P2860
The levels of caspase-cleaved cytokeratin 18 are elevated in serum from patients with lung cancer and helpful to predict the survival.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh
2007年學術文章
@zh-hant
name
The levels of caspase-cleaved ...... lpful to predict the survival.
@en
The levels of caspase-cleaved ...... lpful to predict the survival.
@nl
type
label
The levels of caspase-cleaved ...... lpful to predict the survival.
@en
The levels of caspase-cleaved ...... lpful to predict the survival.
@nl
prefLabel
The levels of caspase-cleaved ...... lpful to predict the survival.
@en
The levels of caspase-cleaved ...... lpful to predict the survival.
@nl
P2093
P1433
P1476
The levels of caspase-cleaved ...... lpful to predict the survival.
@en
P2093
Arzu Yilmaztepe
Engin Ulukaya
Mehmet Karadag
Semra Akgoz
P304
P356
10.1016/J.LUNGCAN.2007.01.015
P50
P577
2007-02-20T00:00:00Z